Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cogentis Therapeutics

Cogentis Therapeutics
2015 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
3 INVESTORS
Description

Developer of disease-modifying therapeutics intended to find cures for a number of neurodegenerative diseases. The company discovers and develops first-in-class therapeutics that prevent neurodegeneration and restore brain function to benefit the lives of those patients and their families, providing medical practitioners with treatments for Alzheimer's disease, frontotemporal dementia, progressive supranuclear palsy and more.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Primary Office
  • 10668 Quarterstaff Road
  • Columbia, MD 21044
  • United States

+1 (443) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cogentis Therapeutics’s full profile, request a free trial.

Cogentis Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator 20-May-2015 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Cogentis Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
MassChallenge Accelerator/Incubator 000 0000 000000 0
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0
OneStart Accelerator/Incubator 000 0000 000000 0

Cogentis Therapeutics Executive Team (8)

Name Title Board
Seat
Contact
Info
J. Kent Werner Ph.D Co-Founder & Chief Executive Officer
Christopher Burch Co-Founder & Chief Operating Officer
Sean Evans Ph.D Co-Founder & Chief Business Development Officer
Benoît Renvoisé Ph.D Co-Founder
Ce Zhang Co-Founder
You’re viewing 5 of 8 executives. Get the full list »